Skip to content
Subscriber Only
Markets
Deals

Teva Accused of Trying to Escape Mexican Drugmaker Deal

  • Rimsa purchased last year for $2.3 billion on expansion plan
  • Teva claims it was misled by Rimsa and plans to fight lawsuit
Updated on

The former owners of a Mexican drugmaker purchased by Teva Pharmaceutical Industries Ltd. last year for $2.3 billion say the Israel-based company is suffering “buyer’s remorse” and looking to get out of the deal.

Teva agreed to buy Representaciones e Investigaciones Medicas SA, known as Rimsa, to expand in emerging markets. On Tuesday, the sons of the company’s founder sued Teva in New York state court alleging it made false accusations of fraud in order to void the purchase.